"That changed on September 18, 2009, when the firm refocused its core business strategy on the international commercialization of its Onko-Sure In Vitro Diagnostic (IVD) Cancer Test Kits and, to a lesser extent, Elleuxe skin care products."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.